CDC-RFA-GH21-2139: Strengthen Capacity of Uganda Ministry of Health and Sub-National Entities to Execute Essential Public Health Functions through Supporting Public Health Workforce Development and Institutional Capacity-Building in the Republic of Uganda under PEPFAR
Closed
This grant is closed. A newer notice from the same program is forecast: Capacity Building for National Immunization Programs in the Eastern Mediterranean Region (CDC-RFA-JG-27-0070). Status: Expected deadline February 12, 2027. It is in our archive of Centers for Disease Control - CGH notices from 2021.
Centers for Disease Control - CGH offered grants to any type of organization. It expected to make one award. Applications closed on April 20, 2021.
From the official notice on Grants.gov, last changed March 25, 2021. Checked November 7, 2026.
- Expected awards1
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | February 19, 2021 |
|---|---|
| Deadline | April 20, 2021 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Most of the money in the 2 programs behind this notice (60% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,000,000 for Year 1, subject to the availability of funds. This NOFO will strengthen capabilities of the Ugandan Ministry of Health (MOH) and its sub-national entities to enhance execution of its essential public health (PH) functions. This NOFO aligns with PEPFAR investments for impact, sustainability, accountability, PH systems, health policies, and PH workforce development. Key components will include support for PH workforce development using training-through-service approaches and cost-effective e-learning methods to build the capacity of health managers to effectively manage the HIV response. In order to enhance institutionalization of PEPFAR investments, the fellows will be drawn from both governmental and non-governmental institutions with the aims of improving leadership capacity for HIV and TB program management at the central level, Regional Referral Hospitals (RRHs), and decentralized levels; increasing use of data for decision-making and accountability; enhancing surveillance and outbreak investigation capabilities; documenting and disseminating HIV and TB studies to inform policy development and review; and sharing best practices across districts and regions. This model will include a two-year public health fellowship program (PHFP) in field epidemiology and capacity-building for frontline health workers in surveillance and outbreak investigations.
Who has won Global AIDS grants before
From fiscal 2021 to 2025, Global AIDS (93.067) awarded $7.6 billion across 521 grant awards, an average of $14.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Trustees of Columbia University in the City of New York | New York | 32 | $684 million |
| Elizabeth Glaser Pediatric AIDS Foundation | District of Columbia | 13 | $387 million |
| Management and Development for Health | 5 | $282 million | |
| Apin Public Health Initiatives LTD/Gte | 4 | $209 million | |
| University of Washington | Washington | 8 | $195 million |
Who has won Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security grants before
From fiscal 2021 to 2025, Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security (93.318) awarded $1.3 billion across 306 grant awards, an average of $4.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| African Field Epidemiology Network LTD | 6 | $147 million | |
| The Task Force for Global Health, Inc. | Georgia | 7 | $138 million |
| World Health Organization, Somalia | 14 | $125 million | |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 3 | $61.5 million |
| The Johns Hopkins University | Maryland | 5 | $42.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-JG-27-0070, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-GH21-2139 still open?
No. It closed on April 20, 2021. A newer notice is forecast: CDC-RFA-JG-27-0070, expected deadline February 12, 2027.
Who can apply for Strengthen Capacity of Uganda Ministry of Health and Sub-National Entities to Execute Essential Public Health Functions through Supporting Public Health Workforce Development and Institutional Capacity-Building in the Republic of Uganda under PEPFAR?
Centers for Disease Control - CGH accepted applications from any type of organization.
What is the deadline for Strengthen Capacity of Uganda Ministry of Health and Sub-National Entities to Execute Essential Public Health Functions through Supporting Public Health Workforce Development and Institutional Capacity-Building in the Republic of Uganda under PEPFAR?
Closed April 20, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won Global AIDS grants before?
The largest recipients over five fiscal years were The Trustees of Columbia University in the City of New York, Elizabeth Glaser Pediatric AIDS Foundation, Management and Development for Health. The program made 521 awards worth $7.6 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)